| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-28 |
| filingDate |
2000-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6fae7a2c35b6c1ac5e022a7c59f2f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f274088993423e15ea19fa675c2cf19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1764beba3bbf3f6511b3597507816f |
| publicationDate |
2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001226288-A |
| titleOfInvention |
Peritoneal deterioration inhibitor and peritoneal dialysis solution |
| abstract |
(57) [Problem] To provide a novel peritoneal deterioration inhibitor capable of suppressing peritoneal deterioration. The peritoneal degradation inhibitor of the present invention contains HGF. The peritoneal deterioration inhibitor of the present invention comprises H It is preferable to further contain a saccharide in addition to GF. The peritoneal degradation inhibitor is capable of converting such a saccharide to 1 ng of HGF at 1 It is preferred to contain about μg to 10 g. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018534117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004269461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007077026-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7013380-B2 |
| priorityDate |
2000-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |